Business Description
![X4 Pharmaceuticals Inc X4 Pharmaceuticals Inc logo](https://static.gurufocus.com/logos/0C0000BCQY.png?14)
X4 Pharmaceuticals Inc
NAICS : 325412
SIC : 2836
ISIN : US98420X1037
Description
X4 Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in the research and development of novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It has the ability to increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.39 | |||||
Equity-to-Asset | 0.01 | |||||
Debt-to-Equity | 56.25 | |||||
Debt-to-EBITDA | -0.48 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 43.3 | |||||
3-Year EPS without NRI Growth Rate | 41.9 | |||||
3-Year FCF Growth Rate | 43.4 | |||||
3-Year Book Growth Rate | -59.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 27.48 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 22.77 | |||||
9-Day RSI | 24.07 | |||||
14-Day RSI | 27.52 | |||||
6-1 Month Momentum % | 31.01 | |||||
12-1 Month Momentum % | -42.92 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.71 | |||||
Quick Ratio | 3.71 | |||||
Cash Ratio | 3.44 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -117.4 | |||||
Shareholder Yield % | -91.4 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -269.76 | |||||
ROA % | -88.23 | |||||
ROIC % | -351.4 | |||||
ROC (Joel Greenblatt) % | -1778.49 | |||||
ROCE % | -99.1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 91.48 | |||||
EV-to-EBIT | -0.57 | |||||
EV-to-EBITDA | -0.57 | |||||
EV-to-Forward-Revenue | 8.48 | |||||
EV-to-FCF | -0.67 | |||||
Earnings Yield (Greenblatt) % | -175.44 | |||||
FCF Yield % | -112.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
X4 Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.636 | ||
Beta | 0.77 | ||
Volatility % | 77.31 | ||
14-Day RSI | 27.52 | ||
14-Day ATR (€) | 0.044911 | ||
20-Day SMA (€) | 0.80779 | ||
12-1 Month Momentum % | -42.92 | ||
52-Week Range (€) | 0.4938 - 1.79 | ||
Shares Outstanding (Mil) | 167.94 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
X4 Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
X4 Pharmaceuticals Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
X4 Pharmaceuticals Inc Frequently Asked Questions
What is X4 Pharmaceuticals Inc(FRA:48Q)'s stock price today?
The current price of FRA:48Q is €0.52. The 52 week high of FRA:48Q is €1.79 and 52 week low is €0.49.
When is next earnings date of X4 Pharmaceuticals Inc(FRA:48Q)?
The next earnings date of X4 Pharmaceuticals Inc(FRA:48Q) is 2024-08-09 Est..
Does X4 Pharmaceuticals Inc(FRA:48Q) pay dividends? If so, how much?
X4 Pharmaceuticals Inc(FRA:48Q) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |